GSK has claimed a new approval for its respiratory syncytial virus (RSV) vaccine Arexvy, currently locked in a battle for market share with rival shots from Pfizer and Moderna, that could lend it ...

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...

The infection commonly referred to as RSV has started losing its hold in other parts of the country, and Dr. Theresa Cullen — the county’s health director — said Wednesday during a news ...

Products Market Alerts MyCollection Price Database Become a Partner Gallery ...

A TB infection may be more severe in those with a history of alcohol misuse. RSV is a common respiratory infection that typically causes mild, cold-like symptoms. However, people with weakened ...

Future Virology. 2014;9(8):753-767.